ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,258.91
-0.74%
Dow Jones
42,313.00
0.00%
Gold vs US Dollar
2,641.235
-0.87%
Brent Oil
71.345
-0.50%
Bitcoin
63,804.44
-2.78%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
30/09/202413:00UK RegulatoryIGI Announces CRADA with National Cancer Institute to Test Proprietary Oral Cbl/b Inhibitor Treatment in Triple Negative Breast Cancer
30/09/202413:00UK RegulatoryIchnos Glenmark Innovation (« IGI ») annonce un accord de collaboration en recherche et développement (« CRADA ») avec le National Cancer Institute (« NCI ») afin de tester un traitement oral exclusif d’inhibiteur de Cbl/b dans le cancer du
30/09/202413:00UK RegulatoryMerus annonce que le premier patient a été traité dans le cadre de l’étude LiGeR-HN1, un essai de Phase III évaluant le pétosemtamab en association avec le pembrolizumab en traitement de première intention contre le CETC r/mTG:2GHMerus NV
30/09/202413:00UK RegulatoryMerus gibt Behandlung des ersten Patient in klinischer Phase-III-Studie LiGeR-HN1 zur Bewertung von Petosemtamab in Kombination mit Pembrolizumab bei rezidivierendem/metastasierendem Plattenepithelkarzinom des Kopfes und Halses in der Erstlinie bekanntTG:2GHMerus NV
30/09/202413:00UK RegulatoryMerus Announces First Patient Dosed in LiGeR-HN1, a Phase 3 Trial Evaluating Petosemtamab in Combination with Pembrolizumab in 1L r/m HNSCCTG:2GHMerus NV
30/09/202413:00UK RegulatoryIGI kündigt kooperative Forschungs- und Entwicklungsvereinbarung mit dem National Cancer Institute zur Untersuchung einer proprietären oralen Cbl/b-Inhibitor-Behandlung bei dreifach negativem Brustkrebs an
30/09/202413:00PR Newswire (US)PA MEDIA APPOINTS SENIOR STANDARD EXECUTIVE JACK LEFLEY AS EDITOR-IN-CHIEF
30/09/202413:00PR Newswire (US)National Cricket League Kicks Off "Cricket for Good": Billions Have Access to Watch a Purpose-Driven Tournament
30/09/202413:00PR Newswire (US)New Team, New Vision: Chunghwa AI Ignites the Future
30/09/202413:00PR Newswire (US)SURVEY: Consumers Are Ignoring Cybersecurity Risks Despite Identify Theft Concerns
30/09/202413:00PR Newswire (US)Sherwin-Williams to Announce Third Quarter 2024 Financial Results on October 22, 2024NYSE:SHWSherwin Williams
30/09/202413:00PR Newswire (US)Cox Automotive Introduces Retail360
30/09/202413:00PR Newswire (US)United Expands Economy Cabin Wine Offerings with Debut of New RoséNASDAQ:UALUnited Airlines Holdings Inc
30/09/202413:00PR Newswire (US)ProPharma Names Dawn Sherman Chief Executive Officer
30/09/202413:00PR Newswire (US)Cheche Group CEO Lei Zhang Acquiring Company Ordinary SharesNASDAQ:CCGCheche Group Inc
30/09/202413:00PR Newswire (US)Critical Minerals Expert Peter Bryant Joins National Center for Energy Analytics Advisory Board
30/09/202413:00PR Newswire (US)A NEW GENDER CLASH EMERGES: GEN Z MEN YEARN FOR TRADITION WHILE GEN Z WOMEN PUSH FOR PROGRESS
30/09/202413:00PR Newswire (US)Arkansas LEARNS Act Catalyzes Launch of $100M Heartland Facilities Fund
30/09/202413:00PR Newswire (US)Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-VaccinationNASDAQ:ARCTArcturus Therapeutics Holdings Inc
30/09/202413:00PR Newswire (US)WHIRLPOOL BRAND LAUNCHES INNOVATIVE FRESHFLOW™ VENT SYSTEM ON NEW SMART FRONT LOAD WASHERS
30/09/202413:00PR Newswire (US)SPIMA Therapeutics Launches to Transform Peptide-Based Immunotherapies and Announces Global Licensing Agreement with SATT AxLR
30/09/202413:00PR Newswire (US)GT's Living Foods Achieves Sustainability Milestone with TRUE Gold Certification for Zero Waste Excellence
30/09/202413:00PR Newswire (US)Hispanic Business Leader Javier Loya Endorses President Trump at Bienvenido Empresarios Luncheon
30/09/202413:00PR Newswire (US)Altudo Becomes Shopify Plus Partner, Delivering Cutting-Edge E-commerce Solutions
30/09/202413:00PR Newswire (US)Emmes Group recognized as a top EDC platform by Everest Group
30/09/202413:00PR Newswire (US)National Cricket League Kicks Off "Cricket for Good": Billions Have Access to Watch a Purpose-Driven Tournament
30/09/202413:00PR Newswire (US)TransPerfect Acquires Paybooks Technologies
30/09/202413:00PR Newswire (US)It's All Treats, No Tricks at Tim Hortons US this Halloween season - baked goods and beverages packed with Halloween favorites like REESE'S and M&M'S® as well as returning fan-favorite Timbits® Trick-or-Treat Buckets
30/09/202413:00PR Newswire (US)Lipocine to Present at H.C. Wainwright 8th Annual MASH Investor ConferenceNASDAQ:LPCNLipocine Inc
30/09/202413:00PR Newswire (US)TXST set to launch 18 new online degree programs in 2025

Your Recent History

LSE
TRP
Tower Resources
LSE
SYME
Supply@me Capital
LSE
SCE
Surface Transforms
LSE
TERN
Tern
LSE
PRU
Prudential
LSE
SOLG
Solgold
LSE
AAZ
Anglo Asian Mining
LSE
VAST
Vast Resources
LSE
SRT
Srt Marine Systems
LSE
ALTN
Altyngold
LSE
EEE
Empire Metals
LSE
VRS
Versarien
LSE
PFC
Petrofac
LSE
AML
Aston Martin Lagonda Glo...
LSE
GGP
Greatland Gold
LSE
GKP
Gulf Keystone Petroleum
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved